Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pace Nordic AB
AB
Active
Org 5595113902
Kornhamstorg 53, 111 27
Stockholm
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2024 · 1 year old
0 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Pace Nordic AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2025: 1M
1M
2025
EBITDA
SEK millions
0M
0M
-1M
-1M
-1M
2025: -1M
-1M
2025
Income statement
SEK thousands
Item
2025
Revenue
926
Staff expenses
−99
EBITDA
−1 074
Depreciation & amort.
—
EBIT
−1 074
Net financials
4
Profit before tax
−1 070
Tax
—
Net profit
−1 070
Balance sheet
SEK thousands
Item
2025
Total assets
2 256
Equity
1 946
Long-term debt
—
Short-term debt
310
Total debt
310
Financial ratios
5-year trend
EBITDA margin
−115,9 %
This company
15,8 %
Market median
This company
Market median
834% below market
2025
2025
Equity ratio
86,3 %
This company
38,2 %
Market median
This company
Market median
126% above market
2025
2025
Return on equity
−55,0 %
This company
18,4 %
Market median
This company
Market median
399% below market
2025
2025
Net profit margin
−115,5 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2025
2025
Asset turnover
0,41×
This company
1,12×
Market median
This company
Market median
63% below market
2025
2025
Debt / equity
0,16×
This company
0,62×
Market median
This company
Market median
74% below market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-12-17 – 2025-12-31
View
PDF
More on Pace Nordic AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
